FLEXIBZUMAB

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark FLEXIBZUMAB was filed as Word mark on 12/09/2021 at the World Intellectual Property Organization.

Trademark Details Last update: June 22, 2023

Trademark form Word mark
File reference 1645677
Countries Australia Brazil Canada China United Kingdom Israel India Iran Japan South Korea Russia Turkey
Base trademark US No. 90792277, June 24, 2021
Application date December 9, 2021
Expiration date December 9, 2031

Trademark owner

200C Patewood Drive,
Room 4148
US

Trademark representatives

43 West 43rd Street #104 New York NY 10036 US

goods and services

05 Pharmaceutical preparations, namely, a drug delivery system comprising antibodies for guiding therapeutic agents to a target tissue; therapeutic pharmaceutical for the treatment of cardiovascular diseases, high blood pressure, arteriosclerosis, aneurysms, diabetes, kidney diseases, and chronic obstructive pulmonary disease (COPD); antibodies for medical and veterinary purposes; antibody preparations for therapeutic purposes; antibodies for targeting drugs to calcified tissue

Trademark history

Date Document number Area Entry
June 20, 2023 2023/25 Gaz KR Rejection
May 31, 2023 2023/22 Gaz CA Rejection
April 3, 2023 2023/16 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
January 25, 2023 2023/4 Gaz BR Rejection
December 1, 2022 2022/48 Gaz JP Rejection
August 25, 2022 2022/34 Gaz TR Rejection
August 16, 2022 2022/34 Gaz IR Rejection
August 2, 2022 2022/32 Gaz AU RAW: Rule 18ter(2)(i) GP following a provisional refusal
July 6, 2022 2022/28 Gaz IL Rejection
June 30, 2022 2022/26 Gaz CN Rejection
June 28, 2022 2022/26 Gaz IN Rejection
May 23, 2022 2022/21 Gaz RU Rejection
May 18, 2022 2022/20 Gaz GB Rejection
February 25, 2022 2022/9 Gaz AU Rejection
December 9, 2021 2022/5 Gaz US Registration

ID: 141645677